Table 1.

Clinical data of the studied individuals

Sample type	Samples (n)	Age (mean±SD)	BMI (mean±SD)	Males	Tumour size (mean±SD)	Rectal bleeding (%)	Alcohol (1st quantile, third quantile) (units/week)	Currently smoking (%)
Tissue controls	59	53.2±13.5	27.4±6.1	44.1	NA	57.7	1 (1, 10)	4
Off CRC	74	66±11.3	28.7±5.7	66.7	3.2±1.8	65.6	2 (1, 10)	10.4
Off Polyps	31	61.6±14.8	28.8±5	71	NA	38.7	1 (1, 10)	13.3
On CRC	65	67±11.6	28.8±5.8	60.9	3.6±2	64.4	2 (0.8, 10)	5
On Polyps	2	76.5±0.7	27.4±0.9	100	NA	50	7.5 (4.2, 10.8)	0
Stool controls	62	63.9±11.1	28.2±5.4	50.9	NA	55.6	1 (0.2, 6.2)	0
Stool CRC	69	65.3±10.8	28.4±6.1	66.7	3.1±1.7	65.5	2 (1, 11.2)	11.3
Stool polyp	23	60.4±13.4	29.3±5.4	78.3	NA	39.1	4 (1, 13.5)	17.4
Swab controls	25	51.5±12.4	27.1±5.5	37.5	NA	57.9	1 (1, 6)	0
Swab CRC	45	65.7±10.9	27.1±5	56.1	3.3±1.9	66.7	2 (1, 9)	0
Swab polyp	21	59.2±15.1	28.5±5.2	71.4	NA	38.1	1 (1, 10)	10

BMI, body mass index; CRC, colorectal cancer.